If you ask Dr. Jethro Hu what keeps him up at night, he will likely answer with “how glioblastoma not only infiltrates all over the brain, but how different parts of the tumor are activated by different genetic alterations.”

In his lecture in the Metabolic Therapies for Cancer Symposium, Dr. Hu dives deep into the findings of a phase 1 trial of a 16-week ketogenic diet in combination with standard-of-care for patients with recently diagnosed glioblastoma.

The results of the study demonstrate that it is possible to use metabolic therapies to treat patients with cancer with the majority of patients were able to maintain ketosis 85% of the time. The ketogenic diet for glioblastoma patients was found to be safe and feasible. However, Dr. Hu does warn that it requires a lot from all parties involved including patients, caregivers, dietitians, and practitioners to manage therapeutic protocols well.

While the preliminary findings are promising for this small cohort of glioblastoma patients, results do vary. If you have any medical concerns, please speak with a medical professional.

We recorded all of the amazing content from Metabolic Health Summit 2022, and it’s now available on our virtual platform for you to watch and enjoy! All content will be available for viewing through October of 2022 and CME credit can be claimed during that time. This activity is jointly provided by Cedars-Sinai Medical Center of Los Angeles and Metabolic Health Initiative. Earn up to a maximum of 22 AMA PRA Category 1 Credits™ (Virtual Access + CME Ticket). To watch Dr. Hu’s full presentation + more than 40 other lectures, in-depth panels, and special interest forums from Metabolic Health Summit 2022, please visit www.metabolichealthsummit.com.